Developer docs
API playgroundTry for free, no card

Search company profiles

CorVent Medical

Full company profile

uuid0002u2k

Namestring
CorVent Medical
Legal namestring
CorVent Medical, Inc.
Company typeenum
Private
Founded yearint
2020
Descriptiontext

CorVent Medical is a Fargo, North Dakota-based privately held medical device company that designs and manufactures critical care respiratory ventilation hardware and software for hospitals, post-acute care facilities, government stockpiles, the military, and rural health systems. Founded in 2020 during the COVID-19 pandemic, the company secured FDA Emergency Use Authorization for its RESPOND-19 ventilator in 2020 and received full FDA 510(k) clearance for the commercially branded RESPOND ventilator in November 2024 — the first U.S.-manufactured ventilator to clear the FDA in over 20 years. The RESPOND ventilator is an ICU-standard, lightweight (under 20 lbs) critical care device supporting invasive and non-invasive ventilation for pediatric (≥38 kg) and adult patients, featuring a 3-hour hot-swappable battery, 99.99% antiviral filtration, EMR and nurse call connectivity, and a 5-year warranty with no service contract requirement.

The company's second product, CorVision, is an AI/ML-driven remote patient monitoring SaaS platform that pairs with RESPOND via Bluetooth to provide real-time waveform visualization, pressure-volume loops, and predictive analytics, with planned FDA 510(k) submission in Q4 2025. CorVent monetizes through capital equipment sales (RESPOND) with planned recurring SaaS revenue (CorVision), targeting hospitals, long-term acute care hospitals (LTCHs), skilled nursing facilities (SNFs), Critical Access Hospitals, the Strategic National Stockpile, state and federal emergency reserves, and the U.S. military. Go-to-market is direct field sales with nationwide demos and product evaluations. The company has raised approximately $53.2M in equity capital plus $6.8M in non-dilutive government funding through early 2026, with the latest capital intended to fund commercialization of CorVision and drive the company to profitability.

Short descriptiontext

CorVent Medical is a privately held U.S. medical device company that designs and manufactures ICU-standard ventilators and AI-driven remote patient monitoring software for hospitals, post-acute care facilities, government stockpiles, the military, and rural health systems.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFargo, United States
HQ citystring
Fargo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mechanical ventilators, critical care ventilation, remote patient monitoring, respiratory care equipment, medical device manufacturing
Industry4 codes
1Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
CodeHLAHAGACPrimaryYes
2Post-Acute & Hospital-at-Home Remote Care Platforms
CodeHLACAFABPrimaryNo
3Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology)
CodeHLALABADPrimaryNo
4Ventilator & Respiratory Care SNFs
CodeHLADADADPrimaryNo
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Critical Care Ventilators and Respiratory Care Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1RESPOND Ventilator Sales
TypeHardware Sales
Description

Sale of FDA 510(k)-cleared mechanical ventilators to hospitals, LTCHs, SNFs, Critical Access Hospitals, government stockpiles (Strategic National Stockpile), and military applications. One-time capital equipment purchase with 5-year warranty included.

corventmedical.com
2CorVision RPM SaaS Platform
TypeSubscription Recurring
Description

Remote patient monitoring software as a service platform integrated with RESPOND ventilators. Subscription-based model expected to fund company to profitability. Planned Q4 2025 510(k) submission for the platform.

corventmedical.com
3Series B Financing Round
TypeLicensing Royalties
Description

Company opened Series B financing round in October 2025 to support CorVision commercialization and continued growth.

businesswire.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1RESPOND Ventilator - Enterprise
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Quote-based pricing for hospitals and healthcare facilities. 5-year standard warranty included. No service or maintenance contracts required, making total cost of ownership equal to purchase price.

corventmedical.com
2CorVision RPM SaaS Platform
ModelSubscriptionBilling cadenceAnnual
Notes

SaaS subscription model expected for CorVision platform. Pricing to be determined upon commercialization.

corventmedical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1RESPOND
Description

RESPOND is a full-featured ICU-standard ventilator designed for simple, safe, and smart respiratory care in acute, post-acute, and stockpile settings.

corventmedical.com
+2 more records
Core offering1 text field

CorVent Medical designs, manufactures, and sells the FDA 510(k)-cleared RESPOND critical care ventilator and the CorVision AI/ML-driven remote patient monitoring SaaS platform. The RESPOND ventilator delivers ICU-standard invasive and non-invasive ventilation with a 5-year warranty and no service contracts, while CorVision wirelessly connects via Bluetooth to provide real-time waveform monitoring and predictive analytics. The combined hardware-software ecosystem is sold to acute care hospitals, post-acute care facilities, government stockpiles, military medical operations, and rural health systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Reduce ICU transfers by 50%
+5 more records
Product overview1 text field

CorVent Medical offers a two-product portfolio centered on respiratory ventilation solutions: the RESPOND® Ventilator (FDA 510(k)-cleared critical care ventilator) as the core hardware product, paired with CorVision™ (AI/ML-driven RPM SaaS platform) as the intelligent software add-on. The products work together via Bluetooth connectivity, enabling remote patient monitoring and predictive analytics for ventilated patients in acute care, post-acute care, and emergency preparedness settings.

Product and service2 records
1RESPOND® Ventilator
CategoryCritical Care Ventilators
Description

ICU-standard critical care ventilator providing invasive and non-invasive ventilation in pressure and volume modes for pediatric (≥38kg) to adult patients. Features include a 5-year standard warranty with no service or maintenance contracts, hot-swappable battery up to 3 hours, EMR and nurse call connectivity, priority-based alarm system, multi-stage antiviral filtration providing 99.99% protection, and a streamlined lightweight design under 20 lbs. Sold to hospitals, LTCHs, SNFs, Critical Access Hospitals, government stockpiles, and military customers.

2CorVision™ RPM SaaS Platform
CategoryRemote Patient Monitoring Software
Description

AI/ML-driven remote patient monitoring SaaS platform that connects wirelessly via Bluetooth to the RESPOND ventilator. Enables real-time monitoring of waveforms, pressure-volume (PV) and pressure-control (PC) loops, displaying PEEP, tidal volume, and respiratory rate. Stores over 4,000 event logs and integrates with hospital EMR systems, telemedicine networks, and rural health infrastructures. Includes predictive intelligence features for ventilation management.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-12-09
Description

Strategic membership in global alliance dedicated to safe surgical, obstetric, trauma, and anesthesia (SOTA) care. Partnership focuses on enhanced access to critical care, capacity building and training, research and development collaboration, and advocacy and policy influence.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-06-20
Description

Donated RESPOND ventilator to NDSU health professions programs for training nursing and respiratory care students. Located in NDSU Research and Technology Park area.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global medical device incumbent whose Puritan Bennett line dominates ICU mechanical ventilation. Directly comparable in ventilator category with vastly larger installed base, GPO contracts, and capital scale.

TypeDirect peer
Description

Swiss specialist in ICU ventilators (Hamilton-G5, C1, C3, C6) competing head-to-head with RESPOND in the critical care ventilator market. Closest direct peer in product category and target customer.

TypeBroad incumbent
Description

German medical/safety technology incumbent offering Evita and Savina ICU ventilator families alongside broader hospital equipment portfolio. Comparable on ventilator functionality and acute-care customer overlap.

TypeBroad incumbent
Description

Large medical equipment OEM offering Carescape R860 ventilator among broader patient monitoring and hospital solutions portfolio. Comparable in serving acute care hospitals with critical care ventilation.

TypeBroad incumbent
Description

Swedish medtech offering Servo-u and Servo-i ventilator lines alongside surgical and ICU solutions. Comparable in ICU ventilator technology with established hospital relationships.

TypeDirect peer
Description

Pure-play respiratory care company with Bellavista and other ventilator platforms. Closely comparable as a focused respiratory vendor targeting ICU and post-acute ventilation.

TypeEmerging player
Description

Chinese medical device manufacturer with SV300/SV600 ventilator lines growing presence in U.S. and global markets. Comparable in targeting cost-conscious hospitals with modern ICU ventilator designs.

TypeBroad incumbent
Description

Philips' hospital ventilation and respiratory care division, including Trilogy and other ventilation platforms. Comparable on respiratory equipment breadth though more diversified across sleep, hospital, and home ventilation.

TypeEmerging player
Description

Chinese respiratory device manufacturer offering ventilators and CPAP/BiPAP platforms. Comparable as a cost-disruptive ventilator competitor targeting emerging markets and budget-sensitive providers.

TypeOthers
Description

Patient monitoring and connected care company with hospital RPM and predictive analytics platforms. Comparable as an adjacent digital health/RPM ecosystem player whose monitoring capabilities could compete with CorVision.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CorVent Medical

Critical Care Ventilators and Respiratory Care Devicescorventmedical.com

CorVent Medical is a privately held U.S. medical device company that designs and manufactures ICU-standard ventilators and AI-driven remote patient monitoring software for hospitals, post-acute care facilities, government stockpiles, the military, and rural health systems.

What CorVent Medical does

CorVent Medical is a Fargo, North Dakota-based privately held medical device company that designs and manufactures critical care respiratory ventilation hardware and software for hospitals, post-acute care facilities, government stockpiles, the military, and rural health systems. Founded in 2020 during the COVID-19 pandemic, the company secured FDA Emergency Use Authorization for its RESPOND-19 ventilator in 2020 and received full FDA 510(k) clearance for the commercially branded RESPOND ventilator in November 2024 — the first U.S.-manufactured ventilator to clear the FDA in over 20 years. The RESPOND ventilator is an ICU-standard, lightweight (under 20 lbs) critical care device supporting invasive and non-invasive ventilation for pediatric (≥38 kg) and adult patients, featuring a 3-hour hot-swappable battery, 99.99% antiviral filtration, EMR and nurse call connectivity, and a 5-year warranty with no service contract requirement.

The company's second product, CorVision, is an AI/ML-driven remote patient monitoring SaaS platform that pairs with RESPOND via Bluetooth to provide real-time waveform visualization, pressure-volume loops, and predictive analytics, with planned FDA 510(k) submission in Q4 2025. CorVent monetizes through capital equipment sales (RESPOND) with planned recurring SaaS revenue (CorVision), targeting hospitals, long-term acute care hospitals (LTCHs), skilled nursing facilities (SNFs), Critical Access Hospitals, the Strategic National Stockpile, state and federal emergency reserves, and the U.S. military. Go-to-market is direct field sales with nationwide demos and product evaluations. The company has raised approximately $53.2M in equity capital plus $6.8M in non-dilutive government funding through early 2026, with the latest capital intended to fund commercialization of CorVision and drive the company to profitability.

CorVent Medical firmographics

Firmographics
Name
CorVent Medical
Legal name
CorVent Medical, Inc.
Website
https://corventmedical.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
CorVent Medical is a privately held U.S. medical device company that designs and manufactures ICU-standard ventilators and AI-driven remote patient monitoring software for hospitals, post-acute care facilities, government stockpiles, the military, and rural health systems.
Ownership category
akta.pro rank

CorVent Medical industry classification

Industry
Product category
Critical Care Ventilators and Respiratory Care Devices
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)
akta.pro secondary industries
Post-Acute & Hospital-at-Home Remote Care Platforms (HLACAFAB), Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD), Ventilator & Respiratory Care SNFs (HLADADAD)

Keywords

  • Mechanical ventilators
  • Critical care ventilation
  • Remote patient monitoring
  • Respiratory care equipment
  • Medical device manufacturing

Where CorVent Medical is headquartered

Location

Headquarters

HQ city
Fargo
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CorVent Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. RESPOND Ventilator Sales: Sale of FDA 510(k)-cleared mechanical ventilators to hospitals, LTCHs, SNFs, Critical Access Hospitals, government stockpiles (Strategic National Stockpile), and military applications. One-time capital equipment purchase with 5-year warranty included.
  2. CorVision RPM SaaS Platform: Remote patient monitoring software as a service platform integrated with RESPOND ventilators. Subscription-based model expected to fund company to profitability. Planned Q4 2025 510(k) submission for the platform.
  3. Series B Financing Round: Company opened Series B financing round in October 2025 to support CorVision commercialization and continued growth.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractRESPOND Ventilator - Enterprise
SubscriptionAnnualCorVision RPM SaaS Platform

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

CorVent Medical product offering

Product offering

Core offering

CorVent Medical designs, manufactures, and sells the FDA 510(k)-cleared RESPOND critical care ventilator and the CorVision AI/ML-driven remote patient monitoring SaaS platform. The RESPOND ventilator delivers ICU-standard invasive and non-invasive ventilation with a 5-year warranty and no service contracts, while CorVision wirelessly connects via Bluetooth to provide real-time waveform monitoring and predictive analytics. The combined hardware-software ecosystem is sold to acute care hospitals, post-acute care facilities, government stockpiles, military medical operations, and rural health systems.

Product overview

CorVent Medical offers a two-product portfolio centered on respiratory ventilation solutions: the RESPOND® Ventilator (FDA 510(k)-cleared critical care ventilator) as the core hardware product, paired with CorVision™ (AI/ML-driven RPM SaaS platform) as the intelligent software add-on. The products work together via Bluetooth connectivity, enabling remote patient monitoring and predictive analytics for ventilated patients in acute care, post-acute care, and emergency preparedness settings.

Differentiator

Problem solved

Functional benefit

Brands

  • RESPOND: RESPOND is a full-featured ICU-standard ventilator designed for simple, safe, and smart respiratory care in acute, post-acute, and stockpile settings.
  • CorVision
  • RESPOND-19

Products and services

  • RESPOND® Ventilator ICU-standard critical care ventilator providing invasive and non-invasive ventilation in pressure and volume modes for pediatric (≥38kg) to adult patients. Features include a 5-year standard warranty with no service or maintenance contracts, hot-swappable battery up to 3 hours, EMR and nurse call connectivity, priority-based alarm system, multi-stage antiviral filtration providing 99.99% protection, and a streamlined lightweight design under 20 lbs. Sold to hospitals, LTCHs, SNFs, Critical Access Hospitals, government stockpiles, and military customers.
  • CorVision™ RPM SaaS Platform AI/ML-driven remote patient monitoring SaaS platform that connects wirelessly via Bluetooth to the RESPOND ventilator. Enables real-time monitoring of waveforms, pressure-volume (PV) and pressure-control (PC) loops, displaying PEEP, tidal volume, and respiratory rate. Stores over 4,000 event logs and integrates with hospital EMR systems, telemedicine networks, and rural health infrastructures. Includes predictive intelligence features for ventilation management.

Quantifiable outcome

  • Reduce ICU transfers by 50%
  • +5 more outcomes

Companies that use CorVent Medical

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles5 records

CorVent Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature4 records

CorVent Medical partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered strategic and minor.

  • G4 AlliancestrategicStrategic or Co-development Partner · 9 December 2024Strategic membership in global alliance dedicated to safe surgical, obstetric, trauma, and anesthesia (SOTA) care. Partnership focuses on enhanced access to critical care, capacity building and training, research and development collaboration, and advocacy and policy influence.
  • North Dakota State University (NDSU)minorStrategic or Co-development Partner · 20 June 2023Donated RESPOND ventilator to NDSU health professions programs for training nursing and respiratory care students. Located in NDSU Research and Technology Park area.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

CorVent Medical competitors and assessment

Company assessment

Broad incumbents

  • Medtronic: Global medical device incumbent whose Puritan Bennett line dominates ICU mechanical ventilation. Directly comparable in ventilator category with vastly larger installed base, GPO contracts, and capital scale.
  • Dräger: German medical/safety technology incumbent offering Evita and Savina ICU ventilator families alongside broader hospital equipment portfolio. Comparable on ventilator functionality and acute-care customer overlap.
  • GE HealthCare: Large medical equipment OEM offering Carescape R860 ventilator among broader patient monitoring and hospital solutions portfolio. Comparable in serving acute care hospitals with critical care ventilation.
  • Getinge: Swedish medtech offering Servo-u and Servo-i ventilator lines alongside surgical and ICU solutions. Comparable in ICU ventilator technology with established hospital relationships.
  • Philips Respironics: Philips' hospital ventilation and respiratory care division, including Trilogy and other ventilation platforms. Comparable on respiratory equipment breadth though more diversified across sleep, hospital, and home ventilation.

Direct peers

  • Hamilton Medical: Swiss specialist in ICU ventilators (Hamilton-G5, C1, C3, C6) competing head-to-head with RESPOND in the critical care ventilator market. Closest direct peer in product category and target customer.
  • Vyaire Medical: Pure-play respiratory care company with Bellavista and other ventilator platforms. Closely comparable as a focused respiratory vendor targeting ICU and post-acute ventilation.

Emerging players

  • Mindray: Chinese medical device manufacturer with SV300/SV600 ventilator lines growing presence in U.S. and global markets. Comparable in targeting cost-conscious hospitals with modern ICU ventilator designs.
  • BMC Medical: Chinese respiratory device manufacturer offering ventilators and CPAP/BiPAP platforms. Comparable as a cost-disruptive ventilator competitor targeting emerging markets and budget-sensitive providers.

Others

  • Masimo: Patient monitoring and connected care company with hospital RPM and predictive analytics platforms. Comparable as an adjacent digital health/RPM ecosystem player whose monitoring capabilities could compete with CorVision.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

CorVent Medical social profiles

Digital presence

CorVent Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CorVent Medical leadership team

Management profile

Number of profiles

Profiles10 records

CorVent Medical funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CorVent Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CorVent Medical

What does CorVent Medical do?

CorVent Medical designs, manufactures, and sells the FDA 510(k)-cleared RESPOND critical care ventilator and the CorVision AI/ML-driven remote patient monitoring SaaS platform. The RESPOND ventilator delivers ICU-standard invasive and non-invasive ventilation with a 5-year warranty and no service contracts, while CorVision wirelessly connects via Bluetooth to provide real-time waveform monitoring and predictive analytics. The combined hardware-software ecosystem is sold to acute care hospitals, post-acute care facilities, government stockpiles, military medical operations, and rural health systems.

Is CorVent Medical a public or private company?

CorVent Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was CorVent Medical founded?

CorVent Medical was founded in 2020. It employs 11 to 50 people.

Where is CorVent Medical based?

CorVent Medical is headquartered in Fargo, United States, in the North America region.

How does CorVent Medical make money?

Three revenue lines are on record. RESPOND Ventilator Sales are the primary driver. The others are corVision RPM SaaS Platform and series B Financing Round.

Who are CorVent Medical's main competitors?

Broad incumbents on record are Medtronic, Dräger, GE HealthCare, Getinge and Philips Respironics. Direct peers are Hamilton Medical and Vyaire Medical. Emerging players are Mindray and BMC Medical. Masimo is listed as an others.

Does CorVent Medical have an API?

No public API is recorded for CorVent Medical.

What industry is CorVent Medical in?

CorVent Medical's product category is Critical Care Ventilators and Respiratory Care Devices. Its primary akta.pro industry code is HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home), with a secondary code of HLACAFAB, Post-Acute & Hospital-at-Home Remote Care Platforms. Its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogCorVent Medical Launches AI/ML-Driven CorVision™ SaaS Platform and Opens Series B FinancingCorVent Medical, a North Dakota-based medtech company, announced the launch of its CorVision™ AI/ML-driven SaaS platform for intelligent ventilation management in intensive care and emergency settings, alongside the opening of its Series B financing round. The company has raised over $45 million through Series A and plans to submit a 510(k) application to the U.S. Food and Drug Administration in November 2025 for regulatory clearance of its digital respiratory care portfolio. CorVent has engaged Burns McClellan, Inc. as investor relations advisor and will attend the J.P. Morgan Healthcare Conference in January 2026 to meet with potential investors.PR NewswireCorVent Medical Announces Jeremy R. Nelson As Chief Operating OfficerCorVent Medical appointed Jeremy R. Nelson as its new global Chief Operating Officer to lead operations, supply chain, and manufacturing functions. This strategic hire supports the company's transition from a startup to a commercial medical device manufacturer as it moves into a new 15,000-square-foot headquarters in Fargo, North Dakota.PR NewswireCorVent Medical sichert sich die CE-Zulassung für sein Intensivbeatmungsgerät RESPOND-19™CorVent Medical, a private medical device company based in Santa Clara, California, has received CE marking approval enabling the commercial launch of its RESPOND-19™ intensive care ventilator across Europe. The device offers invasive and non-invasive respiratory support, filters 99.9% of viral pathogens, operates at lower costs without requiring costly service contracts, and was recently awarded the 2021 Silver Medical Design Excellence Award. To support commercial growth, the company also appointed veteran MedTech finance executive Travis Murphy as Chief Financial Officer.PR NewswireCorVent Medical obtiene la aprobación de la marca CE para su respirador RESPOND-19™CorVent Medical has received CE approval for its RESPOND-19 intensive care ventilator, enabling commercial launch and expansion in the European market. Concurrently, the company appointed Travis Murphy as Chief Financial Officer to support its continued business growth. The device previously secured US Emergency Use Authorization from the FDA and maintains a distribution partnership with Siemens Healthineers.PR NewswireCorVent Medical garante aprovação da marcação CE para seu ventilador para tratamento médico crítico, o RESPOND-19™CorVent Medical received CE marking approval for its RESPOND-19™ ventilator and is prepared to launch the device commercially across Europe, following FDA emergency use authorization obtained in late 2020. The ventilator offers ICU-quality respiratory support with advanced antiviral filtration (99.9% of viral pathogens) and a low total cost of ownership without requiring expensive maintenance contracts. To support commercialization efforts, the company appointed Travis Murphy, an experienced medical technology executive with over 30 years of experience, as Chief Financial Officer.PR NewswireCorVent Medical Secures CE Mark Approval For Its Critical Care RESPOND-19™ VentilatorCorVent Medical, a private medtech company, has received CE Mark approval enabling commercial launch of its RESPOND-19™ Ventilator across Europe. The ventilator system provides ICU-quality respiratory support with built-in antiviral filtration, designed for flexible expansion of critical care capacity at a lower cost of ownership without ongoing service contracts. The company also appointed Travis Murphy, an experienced medtech executive, as CFO to support commercialization efforts.PR NewswireCorVent Medical recibe la aprobación de marcado CE para su ventilador RESPOND-19™ para cuidados intensivosCorVent Medical received CE marking approval for its RESPOND-19™ intensive care ventilator, enabling commercial launch in Europe. To support this expansion, the company appointed Travis Murphy as Chief Financial Officer.PR NewswireCorVent Medical obtient l'approbation du marquage CE pour son ventilateur de soins intensifs RESPOND-19™CorVent Medical received CE marking approval for its RESPOND-19™ intensive care ventilator and is ready to commercialize the device in Europe. The company appointed Travis Murphy, an experienced medical technology executive with over 30 years of experience, as Chief Financial Officer to support its commercial growth. The RESPOND-19 ventilator, designed for flexible ICU capacity expansion, recently won the 2021 Medical Design Excellence Award silver medal in the emergency tools category.PR NewswireCORVENT MEDICAL ANNOUNCES STRATEGIC PARTNERSHIP WITH SIEMENS HEALTHINEERS FOR DISTRIBUTION OF THE RESPOND-19™ VENTILATORCorVent Medical announced a strategic distribution partnership with Siemens Healthineers for the RESPOND-19™ Ventilator in the U.S. market, targeting hospitals, healthcare systems, and government customers. The ventilator, which received Emergency Use Authorization from the FDA earlier this month, complements Siemens Healthineers' existing respiratory care offerings by providing affordable, rapid-deployment critical care ventilation during patient surges. CorVent expects full FDA clearance and CE Mark certification for European market access in 2021.PR NewswireCorVent Medical recibe la autorización de uso de emergencia de la FDA para su nuevo ventilador RESPOND-19™CorVent Medical received Emergency Use Authorization (EUA) from the US FDA on December 8, 2020, for its RESPOND-19™ ventilator designed for primary critical care use. The ventilator establishes a new category of devices optimized for rapid deployment and long-term storage without expensive service contracts, enabling hospitals to scale ventilation capacity during peak demand periods such as pandemics. The device is now commercially available in the United States, with the company targeting CE Mark certification in early 2021.